Published in Int J Cancer on February 15, 1990
Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol (2003) 0.86
NRF2 Signaling Negatively Regulates Phorbol-12-Myristate-13-Acetate (PMA)-Induced Differentiation of Human Monocytic U937 Cells into Pro-Inflammatory Macrophages. PLoS One (2015) 0.79
Dual Ca2+ requirement for optimal lipid peroxidation of low density lipoprotein by activated human monocytes. J Clin Invest (1993) 0.79
Quantitative proteomics reveals a role for epigenetic reprogramming during human monocyte differentiation. Mol Cell Proteomics (2014) 0.79
Interferon-gamma increases cellular calcium ion concentration and inositol 1,4,5-trisphosphate formation in human renal carcinoma cells: relation to ICAM-1 antigen expression. Br J Cancer (1994) 0.75
Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuli. Transl Res (2016) 0.75
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today (1997) 2.89
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature (1999) 2.89
Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment. Int J Cancer (2001) 2.07
Natural history of HLA expression during tumour development. Immunol Today (1993) 2.04
[Arthropathy associated with infection by parvovirus B19. Description of 4 cases]. Med Clin (Barc) (1995) 2.03
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol (1994) 2.02
Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum (1999) 1.90
Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature (1976) 1.45
H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature (1976) 1.43
[Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer]. Actas Urol Esp (2011) 1.41
[Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression]. Actas Urol Esp (2011) 1.39
[Frequency of molecular alterations in heterozygous beta-thalassemia in southern Spain and their relation to the hematologic phenotype]. Sangre (Barc) (1994) 1.38
[Boutonneuse mediterranean fever associated with disseminated intravascular coagulation. Report of 3 cases]. Enferm Infecc Microbiol Clin (1994) 1.38
Comparison of fluid compartments and fluid responsiveness in septic and non-septic patients. Anaesth Intensive Care (2011) 1.29
Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens. Eur Urol (2005) 1.14
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors. Tissue Antigens (2003) 1.09
The crystal structure of tetrameric methionine adenosyltransferase from rat liver reveals the methionine-binding site. J Mol Biol (2000) 1.08
Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection. EMBO J (1995) 1.08
HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer (1989) 1.08
The HLA crossroad in tumor immunology. Hum Immunol (2000) 1.06
HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin Exp Metastasis (1990) 1.04
Prevalence of articular chondrocalcinosis in elderly subjects in a rural area of Catalonia. Ann Rheum Dis (1993) 1.04
High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol (1996) 1.03
Prevalence and determinants of lead intoxication in Mexican children of low socioeconomic status. Environ Health Perspect (1996) 1.03
MHC antigens and malignancy. Nature (1986) 1.02
An arsenic(III)-oxidizing bacterial population: selection, characterization, and performance in reactors. J Appl Microbiol (2002) 1.02
Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx. Int J Cancer (1989) 1.01
Cardiovascular risk factor change--1973-74 to 1980-82: the Minnesota Heart Survey. J Clin Epidemiol (1988) 1.01
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. Int J Cancer (1999) 1.00
Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients. Am Heart J (1983) 1.00
Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line. Cancer Immunol Immunother (1998) 0.99
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol (1991) 0.99
Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther (1995) 0.99
Comparative cytokine gene expression in synovial tissue of early rheumatoid arthritis and seronegative spondyloarthropathies. Br J Rheumatol (1997) 0.97
Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx. Br J Cancer (1990) 0.96
Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res (1997) 0.96
MHC expression on human tumors--its relevance for local tumor growth and metastasis. Semin Cancer Biol (1991) 0.96
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient. Cancer Immunol Immunother (2001) 0.96
Biological implications of HLA-DR expression in tumours. Scand J Immunol (1995) 0.96
Immunoglobulin A and C reactive protein levels in ankylosing spondylitis. Ann Rheum Dis (1987) 0.95
Methylated CpG points identified within MAGE-1 promoter are involved in gene repression. Int J Cancer (1996) 0.95
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens (1998) 0.95
Targeting HLA class I expression to increase tumor immunogenicity. Tissue Antigens (2012) 0.94
Alcohol consumption, low birth weight, and preterm delivery in the National Addiction Survey (Mexico). Int J Addict (1993) 0.93
Multiple mechanisms underlie HLA dysregulation in cervical cancer. Tissue Antigens (2000) 0.93
Expression of HLA G in human tumors is not a frequent event. Int J Cancer (1999) 0.93
Altered MHC class I antigens in tumors. Int J Clin Lab Res (1997) 0.92
Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients: validation of severity criteria. The Grupo Andaluz para el Estudio de las Enfermedades Infecciosas. Am J Respir Crit Care Med (2000) 0.91
MHC antigens on human tumors. Immunol Lett (1991) 0.91
Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol (1997) 0.91
Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy. Scand J Immunol (2009) 0.91
Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line. Tissue Antigens (1996) 0.91
Tracking genetically engineered bacteria: monoclonal antibodies against surface determinants of the soil bacterium Pseudomonas putida 2440. J Bacteriol (1992) 0.91
A sensitive and reliable restriction enzyme assay to distinguish between the mosquitoes Culex torrentium and Culex pipiens. Med Vet Entomol (2010) 0.91
Molecular strategies to define HLA haplotype loss in microdissected tumor cells. Hum Immunol (2000) 0.90
Can the HLA phenotype be used as a prognostic factor in breast carcinomas? Int J Cancer Suppl (1991) 0.90
Tumour immunology, vaccination and escape strategies. Eur J Immunogenet (2003) 0.90
Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI). Br J Pharmacol (2007) 0.90
Protein-bound polysaccharide (PSK) induces cytotoxic activity in the NKL human natural killer cell line. Int J Clin Lab Res (1999) 0.90
Hemodynamic data and angiographic findings after Mustard repair for complete transposition of the great arteries. Circulation (1972) 0.89
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness. Exp Clin Immunogenet (1987) 0.89
Presence of HPV 16 sequences in laryngeal carcinomas. Int J Cancer (1990) 0.89
Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines. Immunogenetics (2006) 0.88
ACTH and beta-endorphin in transcendental meditation. Physiol Behav (1998) 0.88
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens (1998) 0.88
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours. Tissue Antigens (2007) 0.88
HLA class I antigens in human tumors. Adv Cancer Res (1995) 0.88
Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx. Cancer (1990) 0.87
Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res (1991) 0.87